Hypocretin and receptors
From Proteopedia
(Difference between revisions)
(3 intermediate revisions not shown.) | |||
Line 1: | Line 1: | ||
==Hypocretin and Receptors== | ==Hypocretin and Receptors== | ||
- | <StructureSection load='1cq0' size='340' side='right' caption=' | + | <StructureSection load='1cq0' size='340' side='right' caption='NMR structure of orexin-b (PDB code [[1cq0]])'> |
== Hypocretins == | == Hypocretins == | ||
Hypocretins, also called Orexins, are hypothalamic neuropeptides that serve important functions in the regulation of an individual’s sleep/wake cycle, homeostatic systems such as thermoregulation, appetite, and reward processing <ref name="sleep">Latifi, B., Adamantidis, A., Bassetti, C., & Schmidt, M. H. (2018). Sleep-Wake Cycling and Energy Conservation: Role of Hypocretin and the Lateral Hypothalamus in Dynamic State-Dependent Resource Optimization. Frontiers in Neurology, 9. doi:10.3389/fneur.2018.00790</ref>. Orexins come in two forms: <scene name='81/814736/Orexin-a/3'>Orexin-A</scene>, which is 33 amino acids long, and <scene name='81/814736/Orexin-b/2'>Orexin-B</scene>, which is 28 amino acids long <ref name="crystal">Suno, R., Kimura, K. T., Nakane, T., Yamashita, K., Wang, J., Fujiwara, T., … Kobayashi, T. (2018). Article: Crystal Structures of Human Orexin 2 Receptor Bound to the Subtype-Selective Antagonist EMPA. Structure, 26, 7–19.e5. https://doi.org/10.1016/j.str.2017.11.005</ref>. Both Orexin-peptides consist of two amphipathic α-helixes, which have similar properties to the N-terminal α-helixes found on Orexin receptors. Orexin-A can be described as a non-subtype-selective neuropeptide that is capable of binding to either OX1R and OX2R, the two possible Orexin receptors, with roughly equal affinities. However, Orexin-B binds to OX2R with an affinity 10 times greater than its affinity for OX1R <ref name="crystal" />. <scene name='81/814736/Orexin-a/1'>Orexin-A</scene> has a hydrophilic turn induced by two disulfide bonds, allowing hydrophobic residues to be on one face and hydrophilic residues to be on another face. | Hypocretins, also called Orexins, are hypothalamic neuropeptides that serve important functions in the regulation of an individual’s sleep/wake cycle, homeostatic systems such as thermoregulation, appetite, and reward processing <ref name="sleep">Latifi, B., Adamantidis, A., Bassetti, C., & Schmidt, M. H. (2018). Sleep-Wake Cycling and Energy Conservation: Role of Hypocretin and the Lateral Hypothalamus in Dynamic State-Dependent Resource Optimization. Frontiers in Neurology, 9. doi:10.3389/fneur.2018.00790</ref>. Orexins come in two forms: <scene name='81/814736/Orexin-a/3'>Orexin-A</scene>, which is 33 amino acids long, and <scene name='81/814736/Orexin-b/2'>Orexin-B</scene>, which is 28 amino acids long <ref name="crystal">Suno, R., Kimura, K. T., Nakane, T., Yamashita, K., Wang, J., Fujiwara, T., … Kobayashi, T. (2018). Article: Crystal Structures of Human Orexin 2 Receptor Bound to the Subtype-Selective Antagonist EMPA. Structure, 26, 7–19.e5. https://doi.org/10.1016/j.str.2017.11.005</ref>. Both Orexin-peptides consist of two amphipathic α-helixes, which have similar properties to the N-terminal α-helixes found on Orexin receptors. Orexin-A can be described as a non-subtype-selective neuropeptide that is capable of binding to either OX1R and OX2R, the two possible Orexin receptors, with roughly equal affinities. However, Orexin-B binds to OX2R with an affinity 10 times greater than its affinity for OX1R <ref name="crystal" />. <scene name='81/814736/Orexin-a/1'>Orexin-A</scene> has a hydrophilic turn induced by two disulfide bonds, allowing hydrophobic residues to be on one face and hydrophilic residues to be on another face. | ||
+ | |||
+ | See also [[Orexin and Orexin receptor]]. | ||
== Receptors == | == Receptors == | ||
- | Orexin-A and Orexin-B bind with corresponding G-protein-coupled receptors known as <scene name='81/814736/Ox1r/1'>OX1R</scene> and <scene name='81/814736/Ox2r/1'>OX2R</scene>. While both OX1R and OX2R can be found within the brains of mammals, they are unevenly distributed throughout the brain. OX1R and OX2R, both, have an α-helix in their extracellular N-terminal regions. The N-terminal α-helixes serve a critical roll in Orexin-A-mediated neuropeptide activation. Although the structures of the N-terminal α-helixes of both OX1R and OX2R are similar, the orientation varies between the two receptors. While the N-terminal α-helix of <scene name='81/814736/Ox1r/4'> | + | Orexin-A and Orexin-B bind with corresponding G-protein-coupled receptors known as <scene name='81/814736/Ox1r/1'>OX1R</scene> and <scene name='81/814736/Ox2r/1'>OX2R</scene>. While both OX1R and OX2R can be found within the brains of mammals, they are unevenly distributed throughout the brain. OX1R and OX2R, both, have an α-helix in their extracellular N-terminal regions. The N-terminal α-helixes serve a critical roll in Orexin-A-mediated neuropeptide activation. Although the structures of the N-terminal α-helixes of both OX1R and OX2R are similar, the orientation varies between the two receptors. While the N-terminal α-helix of <scene name='81/814736/Ox1r/4'>OX1R</scene> is found to interact with the extracellular loop 2 (ECL2), the N-terminal α-helix of OX2R is found to be parallel to the helix 8 on the intracellular side of the membrane <ref name="crystal" />. Residues around positions 2.61 Å and <scene name='81/814736/Selectivity/1'>3.33 Å</scene> in both OX1R and OX2R play a critical roll in determining the subtype selectivity <ref name="crystal" />. Orexin receptors produce neuroexcitation through postsynaptic depolarization by activating non-selective cation channels, inhibiting K+ channels, and activating Na+/Ca2+ exchange. Additionally, OX1R and OX2R stimulate the release of neurotransmitters through presynaptic actions, and OX1R and OX2R modulate synaptic plasticity. Both Orexin receptors have been shown to couple strongly with Ca2+ ion elevations and phospholipase C. Low concentrations of Orexin causes OX1R stimulation, activating a Ca2+ influx <ref name="signal">Kukkonen, J. P., & Leonard, C. S. (2013). Orexin/hypocretin receptor signalling cascades. British Journal of Pharmacology, 171(2), 314-331. doi:10.1111/bph.12324 </ref>. It has been indicated, directly or indirectly, that OX1R and OX2R can couple to Gq, Gi/o and Gs, three of the four heterotrimeric G-protein families. Studies have also revealed that OX2R can couple differently to Gq, Gi/o and Gs proteins depending on which of the various possible types of tissues OX2R can be found in, the OX2R resides within <ref name="signal" />. Since OX1R and OX2R play important rolls in sleep regulation, sleep disorders, such as narcolepsy, can been caused by mutations of these regulators. Narcolepsy, specifically type 1 narcolepsy, can be caused by mutation of the OX2R gene (HCRTR2)<ref name="crystal" />. |
=='''Functions'''== | =='''Functions'''== | ||
Line 23: | Line 25: | ||
Orexin regulates autonomic and cardiovascular effects associated with sleep and wakefulness. Sleep-associated cardiovascular changes, such as the decrease in blood pressure often referred to as “dipping,” occurs during periods of sleep within a wide range of various species. Orexin plays an important role in regulating blood pressure across behavioral states. A lack of Orexin is linked to lower systemic blood pressure and a failure to properly decrease blood pressure during periods of sleep. Orexin, also, increases sympathetic outflow and has an effect on the hypothalamic-pituitary-adrenal axis that results in an increased release of catecholamine. The activity of Orexin neurons acts as a regulator for the release of corticosterone to the hypothalamic-pituitary-adrenal axis that results in the behavioral responses to stress. <ref name="sleep" /> | Orexin regulates autonomic and cardiovascular effects associated with sleep and wakefulness. Sleep-associated cardiovascular changes, such as the decrease in blood pressure often referred to as “dipping,” occurs during periods of sleep within a wide range of various species. Orexin plays an important role in regulating blood pressure across behavioral states. A lack of Orexin is linked to lower systemic blood pressure and a failure to properly decrease blood pressure during periods of sleep. Orexin, also, increases sympathetic outflow and has an effect on the hypothalamic-pituitary-adrenal axis that results in an increased release of catecholamine. The activity of Orexin neurons acts as a regulator for the release of corticosterone to the hypothalamic-pituitary-adrenal axis that results in the behavioral responses to stress. <ref name="sleep" /> | ||
+ | See also: | ||
+ | *[[Receptor]] | ||
+ | *[[Transmembrane (cell surface) receptors]] | ||
+ | *[[G protein-coupled receptors]] | ||
</StructureSection> | </StructureSection> | ||
==References== | ==References== | ||
<references/> | <references/> |
Current revision
Hypocretin and Receptors
|
References
- ↑ 1.0 1.1 1.2 1.3 1.4 Latifi, B., Adamantidis, A., Bassetti, C., & Schmidt, M. H. (2018). Sleep-Wake Cycling and Energy Conservation: Role of Hypocretin and the Lateral Hypothalamus in Dynamic State-Dependent Resource Optimization. Frontiers in Neurology, 9. doi:10.3389/fneur.2018.00790
- ↑ 2.0 2.1 2.2 2.3 2.4 Suno, R., Kimura, K. T., Nakane, T., Yamashita, K., Wang, J., Fujiwara, T., … Kobayashi, T. (2018). Article: Crystal Structures of Human Orexin 2 Receptor Bound to the Subtype-Selective Antagonist EMPA. Structure, 26, 7–19.e5. https://doi.org/10.1016/j.str.2017.11.005
- ↑ 3.0 3.1 Kukkonen, J. P., & Leonard, C. S. (2013). Orexin/hypocretin receptor signalling cascades. British Journal of Pharmacology, 171(2), 314-331. doi:10.1111/bph.12324